Dr. Cavazzoni has been interim director since spring 2020.
“Having spent most of my career with CDER, I have a deep appreciation of the role. Dr. Cavazzoni’s credentials are of the highest caliber, and I know she will continue to excel in advancing the FDA’s public health mission for the benefit of all,” Dr. Woodcock stated.
Dr. Cavazzoni joined the FDA in 2018 to serve as deputy director for operations at the Center for Drug Evaluation and Research. She was also the acting principal deputy commissioner of food and drugs in early 2019.
More articles on leadership and management:
How health systems are using employee feedback to bounce back from pandemic
American Hospital Association kicks off $1M health equity initiative
Arizona health system removes Chinese dragon sculpture after backlash from Asian community
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
